SHANGHAI WD PHARMACEUTICAL CO LTD has a total of 16 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and medical technology are ENTREGA INC, EGALET LTD and GUANGXI XIAOGULU BIOTECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | China | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Syringes | |
#4 | Implantable devices | |
#5 | Medical purpose containers |
# | Name | Total Patents |
---|---|---|
#1 | Dong Liang Chang | 11 |
#2 | Chen Xishan | 8 |
#3 | Shi Jingmin | 8 |
#4 | Zhang Danyong | 6 |
#5 | Dong Liangchang | 5 |
#6 | Zhang Shizhong | 4 |
#7 | Wang Lin | 4 |
#8 | Jiao Yan | 4 |
#9 | Ma Wenbo | 4 |
#10 | Zhao Wenfang | 3 |
Publication | Filing date | Title |
---|---|---|
WO2021062987A1 | Drug accommodating device of solid oral formulation, and oral administration and delivery apparatus comprising same | |
WO2020143843A1 | Oral drug delivery device | |
EP3797818A1 | Controlled-release system of active pharmaceutical ingredient and preparation method therefor | |
US2021015737A1 | Pharmaceutical composition and preparation method therefor and use thereof | |
WO2019192195A1 | Pharmaceutical composition containing dabigatran etexilate and preparation method thereof | |
WO2019137103A1 | Solid particle, preparation method therefor, and pharmaceutical composition containing solid particle |